PARIS, Sept 28 (Reuters) – Sanofi (SASY.PA) is dropping plans for its own mRNA-based COVID-19 vaccine because of the dominant role of the BioNTech-Pfizer (22UAy.DE)(PFE.N) alliance as well as Moderna… [+3844 chars]
Sanofi ditches mRNA COVID-19 vaccine amid rivals success – Reuters